USP17LA loss enhances T-cell function and anti-tumor activity in murine tumor models. Usp17la-deficient T cells exhibit ...

Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes ...

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also ...

Researchers found that zeaxanthin, long associated with eye health, may also boost the body’s immune response against cancer.

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma ...

The 'Gasoline' artist is an open book when it comes to their health journey. Learn all about the various illnesses and health ...

The event will provide an update on the Company's plans for Phase 2 studies and data from the full Phase 1/2 dose expansion cohort, including from the ESMO oral presentation on Friday, October 17th.

Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response Rate (ORR) at the Highest Dose Level (100 µg) and a 40% ORR at the ...

Acute promyelocytic leukemia (APL) represents a paradigm of targeted therapy in hematologic malignancies. Once regarded as ...